Durvalumab vs Finasteride

Durvalumab vs Finasteride: Overview

This comparison examines the pharmacological differences between Durvalumab and Finasteride.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Finasteride — 5-6 hours.

Chemical Properties

Molecular Formula: Finasteride — C23H36N2O2.

Molecular Weight: Finasteride — 372.5490 g/mol.

Type: Durvalumab — Antibody; Finasteride — Small molecule.